NGS platforms combine specialized instruments, sequencing chemistry, sample preparation methods, imaging or signal detection systems, and computational software to convert biological samples into genomic data. Understanding how these systems work, how sequencing instruments and reagents are manufactured, and which companies develop the underlying technologies provides valuable insight into the expanding genomics industry.

What Is Next-Generation Sequencing?

Next-generation sequencing is a high-throughput genomic technology that determines the order of nucleotides in DNA or RNA by processing large numbers of genetic fragments in parallel. It is also known as massively parallel sequencing or high-throughput sequencing. Unlike traditional Sanger sequencing, which generally analyzes a limited number of DNA fragments at a time, NGS can examine millions of fragments within a single sequencing run.

NGS technology combines sample preparation, sequencing chemistry, specialized instrumentation, signal detection, and bioinformatics. Depending on the experimental design, it can be used to examine an entire genome, selected genes, RNA transcripts, or specific genomic regions associated with a biological process.

The technology is widely used in biomedical research, molecular diagnostics, cancer genomics, infectious disease studies, agricultural genetics, evolutionary biology, and pharmaceutical development. Its flexibility allows researchers to investigate genetic variation, gene expression, microbial communities, and complex biological systems.

How Next-Generation Sequencing Works

The NGS workflow typically includes sample preparation, library construction, sequencing, and computational analysis. Each stage contributes to the quality and usefulness of the final genomic data.

Sample Preparation and DNA or RNA Extraction

The process begins with a biological specimen, such as blood, tissue, cultured cells, plant material, or a microbial sample. Laboratory procedures are used to extract DNA or RNA and assess whether the recovered material is suitable for the intended sequencing application.

Sample quality and quantity are important because degraded nucleic acids, contamination, or insufficient starting material can affect library preparation and sequencing performance. Different specimen types may require specialized extraction methods.

NGS Library Preparation

Library preparation converts extracted DNA or RNA into fragments that can be processed by a sequencing platform. Depending on the workflow, the material may undergo fragmentation, end repair, adapter ligation, amplification, or target enrichment.

Adapters are short, designed DNA sequences that help the fragments interact with the sequencing system and may carry sample identification barcodes. Barcoding allows multiple samples to be combined in one run while retaining the ability to distinguish their results during data analysis.

Library preparation kits, enzymes, magnetic beads, automated liquid-handling instruments, and quality-control equipment are important components of the NGS laboratory supply chain.

Sequencing and Signal Detection

After library preparation, the sequencing library is loaded onto a platform-specific flow cell, chip, or other sequencing component. The instrument applies a particular chemistry or molecular detection method to determine the order of nucleotides.

Depending on the platform, the system may detect fluorescent signals, changes in electrical properties, or signals generated as DNA molecules pass through nanopores. Specialized software converts these signals into nucleotide sequences, often called reads.

The number of reads, read length, sequencing depth, and quality of the data depend on the instrument, chemistry, library, and experimental settings.

Bioinformatics and Genomic Data Analysis

The final stage involves processing sequencing reads using computational tools. Typical operations include quality assessment, alignment to a reference genome or sequence assembly, variant detection, gene-expression analysis, and interpretation of results according to the study's objectives.

Bioinformatics pipelines may use local computing infrastructure, high-performance computing systems, or cloud-based platforms. Data storage, access controls, reproducible workflows, and secure handling of genetic information are important considerations when managing large sequencing datasets.

Major Next-Generation Sequencing Technologies

Different NGS technologies use distinct methods to read genetic material. Selecting an appropriate platform requires consideration of the target, read length, throughput, accuracy, sample requirements, and analytical objectives.

Sequencing by Synthesis (SBS)

Sequencing by synthesis determines DNA sequence by monitoring nucleotide incorporation as a complementary DNA strand is produced. In widely used SBS systems, fluorescently labeled nucleotides and imaging technology allow the instrument to identify successive bases across many DNA fragments in parallel.

This approach supports short-read sequencing, targeted gene panels, whole-genome sequencing, RNA sequencing, and many other genomic applications. Its high-throughput capabilities make it suitable for laboratories processing large sample volumes or performing studies that require extensive genomic coverage.

Semiconductor Sequencing

Semiconductor sequencing detects changes associated with hydrogen ions released during DNA synthesis. Rather than relying on fluorescence imaging, the instrument uses electronic sensors to measure the chemical signals generated as nucleotides are incorporated.

This approach is associated with Ion Torrent sequencing systems. Depending on the platform and application, semiconductor sequencing can support targeted panels, microbial analysis, and other molecular testing workflows.

Nanopore Sequencing

Nanopore sequencing measures changes in electrical current as a DNA or RNA molecule passes through a nanoscale pore. Computational models interpret these signal patterns to infer the sequence of nucleotides.

A major characteristic of nanopore technology is its ability to produce long reads, including reads that span complex genomic regions. Certain workflows can also analyze native DNA or RNA and detect molecular modifications. These capabilities are useful for genome assembly, structural variant analysis, transcriptomics, and real-time sequencing applications.

Single-Molecule Real-Time (SMRT) Sequencing

Single-molecule real-time sequencing observes DNA synthesis at the level of individual DNA molecules. Pacific Biosciences developed this technology for applications requiring long reads and detailed genomic analysis.

HiFi sequencing combines long-read sequencing with repeated observations of individual DNA molecules to produce highly accurate consensus reads. It can support genome assembly, detection of structural variants, analysis of repetitive regions, and studies involving complex genetic variation.

Short-Read and Long-Read Sequencing

Short-read sequencing generates relatively compact DNA reads and is widely used for high-throughput analysis of targeted regions, whole genomes, and gene expression. Long-read sequencing produces much longer sequences, helping researchers resolve repetitive regions, complex rearrangements, and genomic structures that may be difficult to reconstruct using short reads alone.

Neither approach is ideal for every project. Some studies combine short-read and long-read data to obtain complementary information about sequence accuracy, genome structure, and genetic variation.

Types of NGS Platforms and Sequencing Systems

NGS platforms range from compact benchtop instruments to high-throughput systems designed for large sequencing laboratories. Platform selection depends on workload, experimental design, laboratory infrastructure, and data-processing capacity.

Benchtop Sequencing Platforms

Benchtop sequencers are designed for laboratories processing small to moderate sample volumes or performing targeted genomic studies. They may be used in academic research, biotechnology development, molecular diagnostics, and smaller sequencing facilities.

Their suitability depends on the applications supported, instrument throughput, sequencing turnaround time, available chemistry, and workflow requirements. A laboratory should also consider whether the platform supports its intended read length, sample types, and quality standards.

High-Throughput Sequencing Platforms

High-throughput sequencers are designed to generate large amounts of genomic data across many samples or large-scale experiments. They are used by genome centers, pharmaceutical research organizations, large clinical laboratories, and sequencing facilities supporting multi-institutional studies.

These systems require suitable laboratory infrastructure, reagent management, automated sample preparation, data storage, and bioinformatics resources. Their performance should be evaluated using the requirements of the actual research program rather than output capacity alone.

Integrated Sequencing Workflows

Some sequencing systems combine several workflow stages, including library preparation, sequencing, and data analysis, into more integrated processes. Laboratory automation can reduce repetitive manual handling and help standardize procedures across larger sample volumes.

However, the extent of automation varies by platform. Laboratories should assess compatibility between instruments, reagents, consumables, laboratory information management systems, and downstream analytical software before implementing an integrated workflow.

NGS Instrument Manufacturing Processes

Manufacturing next-generation sequencing instruments requires the integration of precision engineering, electronics, optical or electrical sensing systems, fluidics, software, and specialized consumables. The manufacturing process varies according to the sequencing technology and the instrument's intended throughput.

Instrument Design and Engineering

Instrument development begins with system architecture and engineering design. Manufacturers define the instrument's sequencing chemistry, sample capacity, detection mechanism, temperature-control requirements, fluid-handling system, and data-processing capabilities.

Computer-aided design, electronic prototyping, mechanical simulation, and laboratory testing help engineers evaluate components before production. Design considerations include measurement stability, instrument reliability, ease of maintenance, contamination control, and compatibility with platform-specific consumables.

Precision Components and Optical Systems

Sequencing instruments may contain optical detectors, lasers, cameras, electronic sensors, microfluidic components, precision motion systems, and temperature-control assemblies. Optical sequencing systems require accurate illumination and imaging, while nanopore and semiconductor systems depend on specialized electrical measurement components.

Component manufacturing and assembly must follow defined specifications. Alignment, calibration, electrical stability, fluid delivery, and thermal performance are evaluated to ensure that the completed instrument can produce consistent sequencing signals.

Reagent and Consumable Manufacturing

Sequencing reagents are another important part of the NGS manufacturing ecosystem. Depending on the platform, these may include enzymes, nucleotides, buffers, fluorescent reagents, adapter sequences, primers, flow cells, chips, and library preparation kits.

Manufacturers establish controlled production procedures to maintain reagent composition, purity, stability, and lot-to-lot consistency. Packaging and storage conditions are also important because certain biological reagents are sensitive to temperature, moisture, light, or extended storage.

Instrument Assembly and Calibration

During assembly, mechanical, electronic, fluidic, and detection components are integrated into a functioning system. Manufacturers install and configure the control software, test communication between subsystems, and calibrate relevant sensors and detection components.

Instrument testing may include fluid-delivery checks, temperature verification, signal measurements, software validation, and sequencing performance assessments using suitable reference materials. Acceptance criteria depend on the system design and its intended applications.

Quality Assurance and Production Verification

Quality assurance helps confirm that sequencing instruments and consumables meet established specifications. Manufacturers may evaluate sequencing accuracy, read quality, output consistency, instrument stability, and the reproducibility of results across runs.

Documented production procedures, component traceability, supplier qualification, corrective-action processes, and ongoing product monitoring support manufacturing consistency. For products intended for clinical diagnostics, additional quality and regulatory requirements may apply depending on the jurisdiction and intended use.

Global NGS Manufacturers and Suppliers

The global NGS industry includes sequencing instrument developers, reagent manufacturers, genomic analysis companies, sample preparation specialists, and laboratory automation providers. These companies participate in different parts of the sequencing supply chain, and their product portfolios are not interchangeable.

The following organizations illustrate the range of technologies available across the market. Their inclusion is informational and does not represent a ranking or an endorsement.

Illumina

Illumina develops sequencing-by-synthesis technology, sequencing instruments, library preparation products, and genomic analysis solutions. Its systems support applications including whole-genome sequencing, targeted sequencing, RNA sequencing, and population genomics.

Thermo Fisher Scientific

Thermo Fisher Scientific supplies laboratory instruments, molecular biology reagents, sample preparation products, and sequencing-related technologies. Its portfolio includes Ion Torrent semiconductor sequencing systems and associated genomic analysis workflows.

Oxford Nanopore Technologies

Oxford Nanopore Technologies develops nanopore sequencing instruments, flow cells, consumables, and data analysis technologies. Its platforms support applications requiring long reads, real-time data generation, and selected direct DNA or RNA analysis workflows.

Pacific Biosciences

Pacific Biosciences develops SMRT sequencing technology and HiFi sequencing systems. Its technologies are used in genome assembly, structural variant detection, transcript analysis, and other applications that benefit from accurate long reads.

QIAGEN

QIAGEN develops sample preparation systems, nucleic acid extraction technologies, and molecular testing products. These technologies can support upstream workflows used in genomic sequencing laboratories.

Agilent Technologies

Agilent Technologies provides analytical instruments, laboratory equipment, and genomic sample preparation technologies. These products can support DNA quality assessment, library preparation, and related laboratory processes.

10x Genomics

10x Genomics develops technologies for single-cell analysis, gene expression profiling, and spatial biology. Its products can complement NGS platforms by preparing and characterizing complex biological samples for sequencing-based research.

Other Genomics Technology Suppliers

Other organizations contribute specialized reagents, oligonucleotides, library preparation kits, sequencing consumables, and laboratory automation systems. Examples include Twist Bioscience, New England Biolabs, and Bio-Rad Laboratories.

When evaluating NGS manufacturers and suppliers, laboratories should examine the specific instrument or product, compatibility with their sequencing workflow, analytical performance, reagent availability, technical documentation, data analysis options, and applicable regulatory status. A company that supplies sample preparation products may not manufacture sequencing instruments, while a sequencing platform developer may depend on third-party components for particular workflows.

Major Applications of Next-Generation Sequencing

NGS supports a wide range of scientific and industrial applications because it can analyze large amounts of genetic information in a single experiment. The required sequencing method and analysis workflow vary according to the biological question.

Whole-Genome Sequencing

Whole-genome sequencing examines DNA across an organism's genome. It can help researchers identify genetic variants, investigate genome structure, compare organisms, and study inherited or acquired genetic differences.

Applications include human genetics, microbial genomics, agricultural research, evolutionary biology, and biodiversity studies. Data interpretation requires suitable reference sequences, quality control, and analytical methods appropriate to the organism and study objectives.

Whole-Exome and Targeted Gene Sequencing

Whole-exome sequencing focuses primarily on protein-coding regions of the genome, while targeted gene sequencing examines selected genes or genomic regions.

Targeted sequencing is useful when researchers have a defined set of genetic targets to investigate. It can support inherited disease research, oncology studies, biomarker discovery, and other applications that require focused analysis rather than sequencing the entire genome.

RNA Sequencing and Transcriptomics

RNA sequencing, commonly called RNA-seq, examines RNA-derived sequences to investigate gene expression, transcript variation, alternative splicing, and other features of the transcriptome.

Researchers use RNA-seq to understand how cells respond to environmental changes, disease processes, experimental treatments, and developmental signals. Specialized methods can also support single-cell transcriptomics and studies of gene expression across different cell populations.

Cancer Genomics and Molecular Diagnostics

NGS is used in cancer research to identify genetic alterations, investigate tumor heterogeneity, and characterize molecular features associated with disease. Some sequencing-based tests are used in clinical settings to support defined diagnostic or treatment decisions when appropriately validated and authorized.

The clinical meaning of a detected variant depends on the disease, specimen, test, evidence available, and intended use. A genetic finding does not automatically establish a diagnosis or determine an appropriate treatment.

Infectious Disease and Microbial Genomics

Microbial sequencing helps researchers examine bacterial, viral, fungal, and other microbial genomes. It can support pathogen identification, outbreak investigation, antimicrobial resistance research, and the study of microbial evolution.

Metagenomic sequencing can analyze genetic material from multiple organisms within a sample. Because complex specimens may contain host DNA, contaminants, and organisms present at low abundance, careful sample preparation and bioinformatics are important for interpreting the results.

Agricultural Biotechnology and Food Research

In agriculture, NGS supports plant and animal genomics, crop improvement research, genetic diversity analysis, and the study of disease resistance. Researchers can investigate genetic traits associated with plant development, environmental adaptation, and livestock characteristics.

Food research applications include microbial community analysis, investigation of foodborne pathogens, and selected food authenticity studies. The reliability of these applications depends on validated sampling, sequencing, and interpretation methods.

Pharmaceutical and Biotechnology Research

Pharmaceutical and biotechnology researchers use NGS to investigate disease mechanisms, identify potential biomarkers, characterize cell lines, study gene expression, and evaluate biological responses during research and development.

Sequencing can also support studies of gene therapies, cell-based products, and engineered biological systems. The specific analytical approach depends on the product, research question, and relevant quality or regulatory requirements.

Quality Control and Data Accuracy in NGS

Quality control is essential throughout the sequencing workflow because errors introduced during sample preparation, sequencing, or computational analysis can affect the final interpretation.

Sample and Library Quality Assessment

Laboratories assess nucleic acid quantity, integrity, purity, and library concentration using suitable analytical methods. They may also evaluate fragment-size distributions and library composition before loading samples onto a sequencer.

These checks help identify problems that could reduce usable sequencing output or introduce bias into the resulting data.

Sequencing Quality Metrics

Sequencing quality assessment may include base-call quality scores, read depth, coverage uniformity, mapping rates, duplication levels, and the proportion of reads that meet predefined criteria. The relevant metrics depend on the sequencing platform and application.

A large volume of sequencing data does not automatically indicate high-quality results. Laboratories need to evaluate whether the reads adequately cover the regions of interest and whether the data meet the requirements of the intended analysis.

Bioinformatics Validation and Data Security

Bioinformatics pipelines require appropriate testing, version control, documentation, and validation for their intended applications. Reference genomes, annotation databases, analysis settings, and variant-calling methods can influence the results.

Genomic data may contain sensitive personal or familial information. Organizations should therefore implement suitable access controls, secure storage, data governance, and privacy safeguards consistent with applicable laws and research requirements.

Factors to Consider When Selecting an NGS Platform

Selecting a sequencing system requires matching the platform's capabilities with the laboratory's scientific objectives, workload, and infrastructure.

Sequencing Throughput and Read Length

Throughput determines how much sequencing data a platform can generate within a specified period. Read length affects the ability to resolve repetitive regions, structural variants, and complex genomic sequences.

Laboratories should select a configuration that meets their actual analytical needs rather than relying on output capacity or read length as the sole selection criteria.

Accuracy and Application Compatibility

Different sequencing technologies have different error profiles and strengths. The required accuracy depends on whether the study involves rare genetic variants, genome assembly, transcript analysis, microbial identification, or another application.

Platform evaluation should consider validated performance for the intended workflow, including specimen type, sequencing depth, and downstream analysis requirements.

Reagents, Consumables, and Operating Requirements

The availability of compatible reagents, flow cells, chips, library preparation kits, and maintenance components can influence laboratory operations. Instrument uptime, staff training, technical support, and supply continuity should also be considered.

Data Processing and Storage

NGS produces substantial volumes of data that require appropriate computational resources. Laboratories should assess storage capacity, data transfer, software compatibility, analysis performance, backup procedures, and information security before scaling their sequencing operations.

Future Trends in Next-Generation Sequencing

NGS technology continues to develop through advances in sequencing chemistry, sensor design, automation, computational analysis, and genomic research methods.

Long-read sequencing is expanding the ability to characterize complex genome structures, repetitive regions, and certain genetic changes that can be difficult to resolve with short reads. Improvements in single-cell sequencing and spatial biology are helping researchers examine molecular variation among individual cells and within tissue environments.

Automation is also becoming increasingly important in high-throughput laboratories. Integrated sample preparation, liquid handling, quality control, and data analysis can help standardize workflows and reduce repetitive manual procedures.

Artificial intelligence and machine learning are being explored for applications such as variant interpretation, genomic classification, signal analysis, and quality assessment. Their usefulness depends on suitable training data, transparent evaluation, independent validation, and appropriate oversight.

Another area of development is the integration of genomics with transcriptomics, epigenomics, and other molecular data. These multiomics approaches can provide a more comprehensive understanding of biological systems, although they also increase the complexity of data management and interpretation.

Conclusion

Next-generation sequencing has become an important technology for understanding DNA, RNA, and complex biological systems. Its major methods—including sequencing by synthesis, semiconductor sequencing, nanopore sequencing, and single-molecule real-time sequencing—offer different capabilities for short-read, long-read, targeted, and genome-wide analysis.

The NGS industry depends on a connected ecosystem of instrument manufacturers, reagent suppliers, sample preparation specialists, laboratory automation providers, and bioinformatics developers. Manufacturing quality, validated workflows, reliable consumables, and secure data management all contribute to effective sequencing operations.

As genomic research expands across medicine, biotechnology, agriculture, and microbial science, selecting suitable NGS technologies requires a clear understanding of the research objective, required data quality, laboratory capacity, and intended use. Continued advances in sequencing platforms and computational methods are expected to broaden the range of questions that genomic analysis can address.